Hansa Biopharma AB Stock Deutsche Boerse AG
Equities
24H
SE0002148817
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.812 EUR | +2.36% | +4.27% | +55.46% |
07:04pm | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
01:30pm | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |
Sales 2024 * | 239M 22.73M 20.95M 31M | Sales 2025 * | 343M 32.56M 30.01M 44.4M | Capitalization | 2.78B 264M 243M 360M |
---|---|---|---|---|---|
Net income 2024 * | -735M -69.84M -64.38M -95.25M | Net income 2025 * | -712M -67.65M -62.37M -92.27M | EV / Sales 2024 * | 13.6 x |
Net Debt 2024 * | 474M 45.04M 41.52M 61.43M | Net Debt 2025 * | 733M 69.68M 64.24M 95.04M | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
-3.82
x | P/E ratio 2025 * |
-4.53
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.64% |
Latest transcript on Hansa Biopharma AB
1 day | +2.36% | ||
1 week | +4.27% | ||
Current month | +58.83% | ||
1 month | +58.83% | ||
3 months | +38.02% | ||
6 months | +79.47% | ||
Current year | +55.46% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 18-03-19 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 11-30 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 20-05-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 18-05-28 | |
Peter Nicklin
CHM | Chairman | 61 | 22-06-29 |
Mats Blom
BRD | Director/Board Member | 59 | 19-05-21 |
Date | Price | Change |
---|---|---|
24-05-31 | 3.812 | +2.36% |
24-05-30 | 3.724 | -1.95% |
24-05-29 | 3.798 | +12.70% |
24-05-28 | 3.37 | -3.82% |
24-05-27 | 3.504 | -4.16% |
Delayed Quote Deutsche Boerse AG, May 31, 2024 at 04:57 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.25% | 58.06B | |
-5.81% | 40.53B | |
+37.52% | 38.99B | |
+14.00% | 26.7B | |
-12.56% | 26.56B | |
-21.34% | 18.98B | |
-0.89% | 12.17B | |
+23.32% | 12B | |
+24.50% | 11.92B |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock